Frazier Healthcare Partners to bring Dutch biotech company public in SPAC deal Frazier Healthcare Partners’ SPAC has found a partner. The venture firm inked a deal to bring Dutch biotech company NewAmsterdam… Read More
Frazier Life Sciences raises nearly $1B for new venture fund focused on earlier-stage companies Frazier Life Sciences announced the closure of a $987 million fund focused on biopharmaceuticals. The life sciences arm of the… Read More
Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer Alpine Immune Sciences will move a potential treatment for immune conditions into human testing and support its ongoing trials for… Read More
